首页> 美国卫生研究院文献>BMJ Open Diabetes Research Care >Original research: Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study

【2h】

Original research: Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study

机译：原始研究：在美国真实世界中与基础胰岛素相比初次注射2型糖尿病的杜拉鲁肽与基础胰岛素治疗的临床和经济结果：DISPEL研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

To report 1-year clinical and economic outcomes from the retrospective DISPEL (Dulaglutide vs Basal InSulin in Injection Naïve Patients with Type 2 Diabetes: Effectiveness in ReaL World) Study.

机译：报告回顾性DISPEL（杜拉鲁肽与基础胰岛素对2型糖尿病初治患者的作用：在ReaL World中的有效性）的1年临床和经济结果。

著录项

期刊名称 BMJ Open Diabetes Research Care
作者
Reema Mody; Qing Huang; Maria Yu; Hiren Patel; Xian Zhang; Liya Wang; Michael Grabner;
展开▼
作者单位

展开▼
年(卷),期 2019(7),1
年度 2019
页码 -1
总页数 9
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
claims database analysis; insulin delivery; adherence to medications; HbA1c;

机译：索赔数据库分析;胰岛素输送;药物依从性;HbA1c;

相似文献

外文文献
中文文献
专利

1. The INITIATOR study: Pilot data on real-world clinical and economic outcomes in us patients with type 2 diabetes initiating injectable therapy [J] . ThayerS., WeiW., BuysmanE., Advances in therapy. . 2013,第12期

机译：INITIATOR研究：美国2型糖尿病患者开始注射治疗的真实临床和经济结果的试验数据
2. The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy [J] . Sarah Thayer, Wenhui Wei, Erin Buysman, Advances in Therapy . 2013,第12期

机译：INITIATOR研究：美国2型糖尿病患者开始注射治疗的现实世界临床和经济结果的试验数据
3. Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study [J] . Shaloo Gupta, Hongwei Wang, Neil Skolnik, Advances in therapy. . 2018,第1期

机译：治疗剂量2型糖尿病患者的治疗剂量和临床结果，从实际世界环境中与胰岛素狼蛛（每毫升300个单位）进行治疗：回顾性观察研究
4. Clinical and metabolic parameters associated with time in ranges and glucose variability in patients with type 2 diabetes treated with insulin [C] . Julia F. Semenova, Maksim V. Dashkin Conference on Cognitive Sciences, Genomics and Bioinformatics . 2020

机译：胰岛素治疗的2型糖尿病患者的临床和代谢参数与时间范围和葡萄糖变异性相关
5. Incidence of hypoglycemia and associated costs in Type 1and Type 2 diabetes patients treated with insulin analogs vs. human insulin: A retrospective cohort study. [D] . Shah, Hiren P. 2014

机译：使用胰岛素类似物与人胰岛素治疗的1型和2型糖尿病患者的低血糖发生率和相关费用：一项回顾性队列研究。
6. The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy [O] . Sarah Thayer, Wenhui Wei, Erin Buysman, -1

机译：INITIATOR研究：美国2型糖尿病患者开始注射治疗的现实世界临床和经济结果的试验数据
7. Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study [O] . Reema Mody, Qing Huang, Maria Yu, 2019

机译：注射型患者2型糖尿病患者的临床和经济结果与美国真实世界的基础胰岛素相比，在杜拉替纳蛋白酶上与基础胰岛素相比：消除研究

Original research: Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study

摘要

著录项

相似文献

相关主题

期刊订阅